alanine has been researched along with Endotoxin Shock in 18 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study determined the effect of arginine on plasma glucose and insulin regulation during endotoxicosis in order to assess its contribution to glucose dyshomeostasis in the pathogenesis of endotoxin shock." | 3.66 | Insulin hypersecretion and potentiation of endotoxin shock in the rat. ( Filkins, JP; Yelich, MR, 1982) |
| " The association of hypoglycemia and increased arterial alanine and glycine with elevated plasma glucagon implied impaired gluconeogenesis." | 3.66 | Amino acid metabolism in dogs with E. coli bacteremic shock. ( Duff, JH; Groves, AC; Woolf, LI, 1979) |
| "Severe sepsis and septic shock syndromes were observed in 7 (53." | 1.56 | Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. ( Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J, 2020) |
| "Staphylococcus aureus superantigen toxic shock syndrome toxin-1 is a major cause of menstrual toxic shock syndrome." | 1.35 | Novel toxic shock syndrome toxin-1 amino acids required for biological activity. ( Amundson, WH; Brosnahan, AJ; Mantz, MJ; Peterson, ML; Schaefers, MM; Schlievert, PM; Squier, CA, 2008) |
| "In low-flow septic shock (CI, 1." | 1.26 | Proteolysis associated with a deficit of peripheral energy fuel substrates in septic man. ( Benotti, PN; Blackburn, GL; Clowes, GH; Miller, JD; O'Donnel, TF; Ryan, NT, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (55.56) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sanville, B | 1 |
| Corbett, R | 1 |
| Pidcock, W | 1 |
| Hardin, K | 1 |
| Sebat, C | 1 |
| Nguyen, MV | 1 |
| Thompson, GR | 1 |
| Haczku, A | 1 |
| Schivo, M | 1 |
| Cohen, S | 1 |
| Chao, JY | 1 |
| Derespina, KR | 1 |
| Herold, BC | 1 |
| Goldman, DL | 1 |
| Aldrich, M | 1 |
| Weingarten, J | 1 |
| Ushay, HM | 1 |
| Cabana, MD | 1 |
| Medar, SS | 1 |
| Quintana-Ortega, C | 1 |
| Remesal, A | 1 |
| Ruiz de Valbuena, M | 1 |
| de la Serna, O | 1 |
| Laplaza-González, M | 1 |
| Álvarez-Rojas, E | 1 |
| Udaondo, C | 1 |
| Alcobendas, R | 1 |
| Murias, S | 1 |
| Brosnahan, AJ | 1 |
| Schaefers, MM | 1 |
| Amundson, WH | 1 |
| Mantz, MJ | 1 |
| Squier, CA | 1 |
| Peterson, ML | 1 |
| Schlievert, PM | 1 |
| Hu, J | 1 |
| Dubois, V | 1 |
| Chaltin, P | 1 |
| Fiten, P | 1 |
| Dillen, C | 1 |
| Van den Steen, PE | 1 |
| Opdenakker, G | 1 |
| Yelich, MR | 1 |
| Filkins, JP | 3 |
| James, JH | 1 |
| Fang, CH | 1 |
| Schrantz, SJ | 1 |
| Hasselgren, PO | 1 |
| Paul, RJ | 1 |
| Fischer, JE | 1 |
| Hong, KW | 1 |
| Kim, KE | 1 |
| Rhim, BY | 1 |
| Lee, WS | 1 |
| Kim, CD | 1 |
| Kiefer, P | 1 |
| Tugtekin, I | 1 |
| Wiedeck, H | 1 |
| Vogt, J | 1 |
| Wachter, U | 1 |
| Bracht, H | 1 |
| Geldner, G | 1 |
| Georgieff, M | 1 |
| Radermacher, P | 1 |
| Clowes, GH | 2 |
| Martin, H | 1 |
| Walji, S | 1 |
| Hirsch, E | 1 |
| Gazitua, R | 1 |
| Goodfellow, R | 1 |
| Woolf, LI | 1 |
| Groves, AC | 1 |
| Duff, JH | 1 |
| Kuttner, RE | 1 |
| Spitzer, JJ | 1 |
| O'Donnel, TF | 1 |
| Blackburn, GL | 1 |
| Ryan, NT | 1 |
| Benotti, PN | 1 |
| Miller, JD | 1 |
| Metzler, B | 2 |
| Rettenmeier, AW | 2 |
| Wodarz, I | 1 |
| Schmahl, FW | 2 |
| Bauer, B | 1 |
| Ishida, K | 1 |
| Totsuka, M | 1 |
| Hayasaka, H | 1 |
| Cornell, RP | 1 |
1 trial available for alanine and Endotoxin Shock
| Article | Year |
|---|---|
Effect of dopexamine on hepatic metabolic activity in patients with septic shock.
Topics: Adult; Aged; Alanine; Blood Pressure; Dopamine; Female; Glucose; Glutamic Acid; Hemodynamics; Humans | 2001 |
17 other studies available for alanine and Endotoxin Shock
| Article | Year |
|---|---|
A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Community-Acquired Infections; COVID-19; | 2020 |
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea | 2020 |
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antivira | 2021 |
Novel toxic shock syndrome toxin-1 amino acids required for biological activity.
Topics: Alanine; Amino Acids; Animals; Bacterial Toxins; Base Sequence; Binding Sites; Cell Membrane Permeab | 2008 |
Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library.
Topics: ADAM Proteins; ADAM17 Protein; Alanine; Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ma | 2006 |
Insulin hypersecretion and potentiation of endotoxin shock in the rat.
Topics: Alanine; Animals; Arginine; Blood Glucose; Homeostasis; Hyperinsulinism; Insulin; Insulin Secretion; | 1982 |
Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis.
Topics: Aerobiosis; Alanine; Amino Acids; Animals; Dose-Response Relationship, Drug; Glucose; Glutamic Acid; | 1996 |
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock.
Topics: Alanine; Animals; Disease Models, Animal; Enzyme Inhibitors; Escherichia coli; Lipopolysaccharides; | 1998 |
Blood insulin responses to blood glucose levels in high output sepsis and spetic shock.
Topics: Adult; Aged; Alanine; Blood Glucose; Cardiac Output; Escherichia coli Infections; Female; Glucose To | 1978 |
Amino acid metabolism in dogs with E. coli bacteremic shock.
Topics: Alanine; Amino Acids; Animals; Blood Gas Analysis; Blood Pressure; Blood Urea Nitrogen; Dogs; Escher | 1979 |
Gluconeogenesis from alanine in endotoxin-treated dogs.
Topics: Alanine; Animals; Blood Glucose; Dogs; Gluconeogenesis; Lactates; Shock, Septic | 1978 |
Proteolysis associated with a deficit of peripheral energy fuel substrates in septic man.
Topics: Adult; Aged; Alanine; Amino Acids; Blood Glucose; Energy Metabolism; Fatty Acids, Nonesterified; Fem | 1976 |
Changes of serum amino acid concentrations in experimentally induced endotoxic shock. The significance of hyperalaninemia in the prediction of lethality.
Topics: Alanine; Amino Acids; Animals; Gabexate; Guanidines; Male; Prognosis; Protease Inhibitors; Rabbits; | 1989 |
Serum amino acids in experimentally induced endotoxic shock: the prognostic significance of hyperalaninemia.
Topics: Alanine; Amino Acids; Animals; Endotoxins; Escherichia coli; Hematocrit; Hemoglobins; Kinetics; Male | 1989 |
[Alanine metabolism in the skeletal muscle and plasma in endotoxemia].
Topics: Alanine; Animals; Glycine; Muscles; Proline; Rabbits; Sepsis; Shock, Septic | 1985 |
Hypoglycemia and depressed hepatic gluconeogenesis during endotoxicosis in lead-sensitized rats.
Topics: Alanine; Animals; Blood Glucose; Endotoxins; Fructose; Gluconeogenesis; Hypoglycemia; Lactates; Lead | 1973 |
Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock.
Topics: Alanine; Animals; Blood Glucose; Carbon Radioisotopes; Depression, Chemical; Endotoxins; Fasting; Gl | 1974 |